Clinical Trials
Finding out about ongoing clinical trials - You should be able to obtain information from the doctor treating you for mesothelioma. Also, call 1-800-362-1479 if you have any questions about clinical trials. The trials listed below are the most current available.What are the benefits of participating in a clinical trial?
- Standard treatments for mesothelioma have not proved very effective, so you may not have much to lose.
- You may not qualify for certain standard treatments for mesothelioma, such as surgery, because of your condition.
- During the trials, doctors and nurses with expertise in treating mesothelioma will closely monitor your health for side effects and changes in your condition.
- Part of the cost of treating your mesothelioma may be free.
- Personal satisfaction in advancing the treatment of mesothelioma and, some day, in the development of a cure.
What are the risks involved?
While strong efforts are made to ensure the safety of persons participating in clinical trials, some risks remain. As with all possible treatments of mesothelioma, discuss the risks with your doctor before you decide to participate.
Also, before you begin a mesothelioma clinical trial, you will be required to sign an informed consent form. By signing this document, you are stating that a healthcare provider has explained the risks and benefits associated with the mesothelioma treatment, and that you have agreed to the participation.
Also, before you begin a mesothelioma clinical trial, you will be required to sign an informed consent form. By signing this document, you are stating that a healthcare provider has explained the risks and benefits associated with the mesothelioma treatment, and that you have agreed to the participation.
Some of the questions you might ask your doctor:
- What does the mesothelioma trial hope to accomplish?
- What are the chances of successfully treating my mesothelioma using standard therapies?
- What side effects are expected, and are these worse than standard treatments of mesothelioma?
- How long will the mesothelioma trial last?
- What company or university is sponsoring the mesothelioma trial?
- What will I have to pay for the mesothelioma treatment?
- Will participating prevent me from being treated with other mesothelioma therapies?
ClinicalTrials.gov: Open Studies | Mesothelioma | received in the last 365 days
Studies found on ClinicalTrials.gov by a search of: Open Studies | Mesothelioma | received in the last 365 days
last updated: Mar 10 2010 8:49 AM
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: cediranib maleate; Drug: cisplatin; Drug: pemetrexed disodium; Other: placebo
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Not yet recruiting - verified February 2010 - Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: everolimus
Sponsors: Memorial Sloan-Kettering Cancer Center; Novartis Pharmaceuticals
Recruiting - verified December 2009 - Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
Sponsor: Columbia University
Recruiting - verified October 2009 - A Study of Cetuximab Combined With Cisplatin or Carboplatin/Pemetrexed as First Line Treatment in Patients With Malignant Pleural Mesothelioma.
Condition: Cancer
Intervention: Drug: Cetuximab (Erbitux)
Sponsors: University Hospital, Ghent; Merck
Not yet recruiting - verified October 2009 - An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Condition: Mesothelioma
Interventions: Drug: MORAb-009; Drug: Premetrexed; Drug: Cisplatin
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009 - Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
Conditions: Malignant Mesothelioma; Pulmonary Complications
Interventions: Genetic: microarray analysis; Genetic: protein expression analysis; Genetic: proteomic profiling; Other: laboratory biomarker analysis
Sponsors: Barbara Ann Karmanos Cancer Institute; National Cancer Institute (NCI)
Recruiting - verified May 2009 - Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
Conditions: Malignant Mesothelioma; Metastatic Cancer
Interventions: Other: laboratory biomarker analysis; Procedure: study of high risk factors
Sponsor: University Hospital, Caen
Recruiting - verified July 2009 - Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma
Conditions: Mesothelioma; Pleural Mesothelioma
Interventions: Drug: Pemetrexed; Drug: Cisplatin
Sponsors: University Health Network, Toronto; Eli Lilly and Company
Recruiting - verified March 2010 - Collecting Tumor Samples From Patients With Gynecological Tumors
Condition: Cancer
Intervention: Other: biologic sample preservation procedure
Sponsors: Gynecologic Oncology Group; National Cancer Institute (NCI)
Recruiting - verified March 2010